Researchers from University of Tabuk Report Recent Findings in Diabetic Nephropathy (Metformin Suppresses Lrg1 and Tgf Beta 1/alk1-induced Angiogenesis and Protects Against Ultrastructural Changes In Rat Diabetic Nephropathy).

Keywords: Tabuk; Saudi Arabia; Asia; Angiogenesis; Antidiabetic Agents; Biguanides; Diabetes Complications; Diabetes Mellitus; Diabetic Nephropathy; Drugs and Therapies; Health and Medicine; Hypoglycemic Agents; Intercellular Signaling Peptides and Proteins; Kidney Diseases and Conditions; Metformin; Metformin Therapy; Nephrology; Nephropathy; Non-Sulfonylureas; Nutritional and Metabolic Diseases and Conditions; Pharmaceuticals; Risk and Prevention; Transforming Growth Factors EN Tabuk Saudi Arabia Asia Angiogenesis Antidiabetic Agents Biguanides Diabetes Complications Diabetes Mellitus Diabetic Nephropathy Drugs and Therapies Health and Medicine Hypoglycemic Agents Intercellular Signaling Peptides and Proteins Kidney Diseases and Conditions Metformin Metformin Therapy Nephrology Nephropathy Non-Sulfonylureas Nutritional and Metabolic Diseases and Conditions Pharmaceuticals Risk and Prevention Transforming Growth Factors 2023 FEB 6 (NewsRx) -- By a News Reporter-Staff News Editor at Diabetes Week -- A new study on Kidney Diseases and Conditions - Diabetic Nephropathy is now available. Tabuk, Saudi Arabia, Asia, Angiogenesis, Antidiabetic Agents, Biguanides, Diabetes Complications, Diabetes Mellitus, Diabetic Nephropathy, Drugs and Therapies, Health and Medicine, Hypoglycemic Agents, Intercellular Signaling Peptides and Proteins, Kidney Diseases and Conditions, Metformin, Metformin Therapy, Nephrology, Nephropathy, Non-Sulfonylureas, Nutritional and Metabolic Diseases and Conditions, Pharmaceuticals, Risk and Prevention, Transforming Growth Factors. [Extracted from the article]